| Dr Bruce Carlton Smith, DDS | |
|
1001 N 1st St, Albemarle, NC 28001-2805 | |
| (704) 983-2400 | |
| Not Available |
| Full Name | Dr Bruce Carlton Smith |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 1001 N 1st St, Albemarle, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447378211 | NPI | - | NPPES |
| 8997878 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | NC4256 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bruce Carlton Smith, DDS 1001 N 1st St, Albemarle, NC 28001-2805 Ph: (704) 983-2400 | Dr Bruce Carlton Smith, DDS 1001 N 1st St, Albemarle, NC 28001-2805 Ph: (704) 983-2400 |
News Archive
Non-small cell lung cancer (NSCLC) survivors who never smoked or who are former smokers at the time of diagnosis have a lower risk of developing secondary primary lung cancers (SPLC) compared to those who are current smokers, suggesting that increased tobacco exposure is associated with a higher risk of SPLC, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting.
Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart's retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a portable, non-invasive monitor that can determine, in one minute and without drawing blood, whether chemotherapy patients have a reduced number of white blood cells that could lead to infections.
Today Biogen Idec and Abbott announced additional results from the SELECT Phase 2b trial, the first of two registrational studies designed to evaluate the investigational compound daclizumab high-yield process in people with relapsing-remitting multiple sclerosis.
YM BioSciences Inc., the cancer drug development company, today announced that the first patient has been dosed in its 700 patient Phase III registration trial.
› Verified 6 days ago
Dr. Mindy Morgan Turner, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1000 N 1st St, Suite 3, Albemarle, NC 28001 Phone: 704-986-3845 Fax: 704-986-3847 | |
Dr. Stacy L Dinges, D.S.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1000 N 1st St Ste 3, Albemarle, NC 28001 Phone: 704-986-3845 Fax: 704-986-3847 | |
James Darrell Mansfield, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1907 Highway 52 N, Albemarle, NC 28001 Phone: 704-983-6111 Fax: 704-983-4560 | |
Dr. Hanna Lynn Smith, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1001 N 1st St, Albemarle, NC 28001 Phone: 704-438-9440 | |
Jihun Moon, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 255 N 2nd St, Albemarle, NC 28001 Phone: 704-983-2131 Fax: 704-983-2132 | |
Dr. Robert F Overcash Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 229 N 1st St, Albemarle, NC 28001 Phone: 704-982-5811 Fax: 704-982-5686 |